A Deregulated PI3K-AKT Signaling Pathway in Patients with Colorectal Cancer

BackgroundMolecular switches in phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway may serve as potential targets for the treatment of colorectal cancer (CRC). This study aims to profile the gene alterations involved in PI3K-AKT signaling pathway in patients with CRC.MethodsTumoral and matched peritumoral tissues were collected from 15 CRC patients who went routine surgery. A human PI3K-AKT signaling pathway polymerase chain reaction (PCR) array, which profiled the transcriptional changes of a total number of 84 genes involved in the PI3K-AKT pathway, was then applied to determine the gene alterations in CRC tumoral tissue with matched peritumoral tissue as a healthy control. Subsequent real-time reverse transcription PCR and western blot (WB) with different subgroups of CRC patients were then performed to further validate the array findings.ResultsThe PCR array identified 14 aberrantly expressed genes involved in the PI3K-AKT signaling pathway in CRC tumoral tissue, among which 12 genes, CCND1, CSNK2A1, EIF4E, EIF4EBP1, EIF4G1, FOS, GRB10, GSK3B, ILK, PTK2, PTPN11, and PHEB were significantly up-modulated (> two fold) while the remaining two, PDK1 and PIK3CG, were down-regulated (> two fold). These genes involve in the regulation of gene transcription and translation, cell cycle, and cell growth, proliferation, and differentiation. The real-time reverse transcription PCR validation agreed with the array data towards the tested genes, CCND1, EIF4E, FOS, and PIK3CG, while it failed to obtain similar result for PDK1. Interestingly, the WB analyses were further consistent with the PCR results that the protein levels of CCND1, EIF4E, and FOS were apparently up-regulated and that protein PIK3CG was down-modulated.ConclusionTaken together, the present study identified a deregulated PI3K-AKT signaling pathway in CRC patients, which might serve as therapeutic target(s).

[1]  Lewis C Cantley,et al.  PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.

[2]  G. Sauter,et al.  Cyclin D1 gene amplification is highly homogeneous in breast cancer , 2014, Breast Cancer.

[3]  E. Wagner,et al.  Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. , 2012, The Journal of clinical investigation.

[4]  C. Ren,et al.  The role of CD29-ILK-Akt signaling-mediated epithelial–mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells , 2015, Medical Oncology.

[5]  K. Jang,et al.  CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed Patients. , 2016, The American journal of pathology.

[6]  Masafumi Ito,et al.  Down-regulation of PIK3CG, a catalytic subunit of phosphatidylinositol 3-OH kinase, by CpG hypermethylation in human colorectal carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  R. Rhoads.  eIF4E: New Family Members, New Binding Partners, New Roles* , 2009, The Journal of Biological Chemistry.

[8]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[9]  R. Bostick,et al.  Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. , 2003, Cancer research.

[10]  K. Borden,et al.  Phosphorylation of the Eukaryotic Translation Initiation Factor eIF4E Contributes to Its Transformation and mRNA Transport Activities , 2004, Cancer Research.

[11]  B. L. Caputto,et al.  Growth of Peripheral and Central Nervous System Tumors Is Supported by Cytoplasmic c-Fos in Humans and Mice , 2010, PloS one.

[12]  M. Patel,et al.  Site Specificity of Four Pyruvate Dehydrogenase Kinase Isoenzymes toward the Three Phosphorylation Sites of Human Pyruvate Dehydrogenase* , 2001, The Journal of Biological Chemistry.

[13]  L. Cantley,et al.  Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation , 1985, Nature.

[14]  G. Yoon,et al.  Clinical Implication of Serine Metabolism-Associated Enzymes in Colon Cancer , 2015, Oncology.

[15]  A. Gingras,et al.  mTOR signaling to translation. , 2004, Current topics in microbiology and immunology.

[16]  G. Mills,et al.  Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis. , 2010, Cancer research.

[17]  P. Levine,et al.  Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer , 2009, Nature Cell Biology.

[18]  N. Sonenberg,et al.  Signalling to eIF4E in cancer , 2015, Biochemical Society transactions.

[19]  Krister Wennerberg,et al.  The Ras superfamily at a glance , 2005, Journal of Cell Science.

[20]  P. Rocchi,et al.  The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer , 2015, Advances in Protein Chemistry and Structural Biology.

[21]  F. Zwartkruis,et al.  Rheb and Rags come together at the lysosome to activate mTORC1. , 2013, Biochemical Society transactions.

[22]  Jürgen Weitz,et al.  Colorectal cancer , 2005, The Lancet.

[23]  J. Graff,et al.  eIF-4E expression and its role in malignancies and metastases , 2004, Oncogene.

[24]  P. Angel,et al.  The transcription factor Fos: a Janus-type regulator in health and disease. , 2009, Histology and histopathology.

[25]  L. Primo,et al.  PDK1: A signaling hub for cell migration and tumor invasion. , 2015, Biochimica et biophysica acta.

[26]  Shih-Chieh Lin,et al.  Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer. , 2011, The American journal of pathology.

[27]  S. Volinia,et al.  Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. , 1995, Science.

[28]  H. Jiang,et al.  Constitutively active Rheb induces oncogenic transformation , 2008, Oncogene.

[29]  J. Huot,et al.  Role of Cancer Microenvironment in Metastasis: Focus on Colon Cancer , 2008, Cancer Microenvironment.

[30]  M. Pagano,et al.  Cyclin D1 is a nuclear protein required for cell cycle progression in G1. , 1993, Genes & development.

[31]  C. Teng,et al.  eIF4E binding protein 1 expression is associated with clinical survival outcomes in colorectal cancer , 2015, Oncotarget.

[32]  L. Cantley,et al.  New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Volm,et al.  Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  R. Denton,et al.  Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1) , 2001, Current Biology.

[35]  Ji Luo,et al.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.

[36]  P. Hawkins,et al.  The Gβγ Sensitivity of a PI3K Is Dependent upon a Tightly Associated Adaptor, p101 , 1997, Cell.

[37]  Gwang Lee,et al.  Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target , 2012, International journal of oncology.

[38]  Y. Shim,et al.  Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro , 2015, BMC Cancer.

[39]  P. Ross,et al.  The role of the PI3K pathway in colorectal cancer. , 2015, Critical reviews in oncology/hematology.

[40]  J. Ptak,et al.  High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.

[41]  P. Hawkins,et al.  The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. , 1997, Cell.

[42]  Ahmedin Jemal,et al.  Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.

[43]  Hans-Peter Lenhof,et al.  Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26‐27 in squamous cell carcinoma of the lung , 2007, International journal of cancer.

[44]  S. Dedhar,et al.  Integrin-linked kinase: Not so ‘pseudo’ after all , 2011, Oncogene.

[45]  F. Tamanoi,et al.  Recent progress in the study of the Rheb family GTPases. , 2014, Cellular signalling.

[46]  B. Neel,et al.  The role of Shp2 (PTPN11) in cancer. , 2007, Current opinion in genetics & development.

[47]  M. Gleave,et al.  Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma , 2015, Molecular Cancer Therapeutics.

[48]  P. Picci,et al.  C-myc and c-fos in Human Osteosarcoma: Prognostic Value of mRNA and Protein Expression , 1998, Oncology.

[49]  Olivier Poch,et al.  Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis , 2004, Oncogene.